|
| Thursday, December 12, 2024 |
|
|
NEC Announces Interim Results from Phase 1 Clinical Trial of NECVAX-NEO1, an AI-Driven Personalized Oral Cancer Vaccine, at ESMO Immuno-Oncology Congress 2024 |
| NEC Bio Therapeutics today presents 24-week promising interim results from an ongoing Phase 1 basket clinical trial of an orally administered cancer vaccine, NECVAX-NEO1, used in combination with checkpoint inhibitors (CPI) for treating patients with solid tumors. more info >> |
|
| Monday, December 9, 2024 |
|
|
NEC begins sale of 100G QSFP28 ZR4 single-fiber bi-directional optical transceiver |
| NEC Corporation (TSE: 6701) has expanded its lineup of optical transceivers for 100Gb/s transmission, and has started selling the new "100G QSFP28 ZR4 BiDi," which extends transmission distance to 80km, from today. more info >> |
|
| Friday, November 29, 2024 |
|
|
JAL and NEC Test AI-Powered Carry-On Baggage Analysis Solution |
| Japan Airlines Co., Ltd. (JAL) and NEC Corporation (NEC) have jointly conducted a trial of the "NEC Baggage Counting Solution"(1), which uses artificial intelligence (AI) to automatically analyze the quantity and types of carry-on baggage at boarding gates. more info >> |
|
| Wednesday, November 20, 2024 |
|
|
Start of Demonstration Test of Two-Phase Direct-to-Chip Cooling in the Air-Cooled Data Center |
| Mitsubishi Heavy Industries, Ltd. (MHI), NTT Communications Corporation (NTT Com), and NEC Networks & System Integration Corporation (NESIC), will begin demonstration testing in December to increase the cooling capacity of data centers without major modifications to existing facilities by introducing high-performance servers equipped with two-phase direct-to-chip cooling(Note1) systems to data centers currently in operation. more info >> |
|
| Monday, November 18, 2024 |
|
|
World's First Successful Trial of Quantum Tokens Created Using Quantum Technology |
| NEC Corporation today announced a successful trial of tokens(1) created using quantum technology (quantum tokens) in cooperation with Tokyo-based Mitsui & Co., Ltd. (Mitsui) and U.S.-based Quantinuum. more info >> |
|
|
富士通など、世界初 スーパーコンピュータ「富岳」を用いてグラフ解析性能200 TeraTEPSを突破 |
| 理化学研究所、東京科学大学、株式会社フィックスターズ、日本電信電話株式会社、富士通株式会社による共同研究グループ※は、大規模グラフ解析に関するスーパーコンピュータの国際的な性能ランキングである「Graph500」のBFS（Breadth-First Search：幅優先探索）部門において、スーパーコンピュータ「富岳」（注1）の測定結果を大幅に向上させ、世界第1位を獲得しました。 more info >> |
|
| Friday, December 17, 2021 |
|
|
NEC Establishes New US$150 Million CVC Fund |
| NEC Corporation (TSE: 6701) today announced the establishment of the "NEC Orchestrating Future Fund," a corporate venture capital (CVC) fund aiming to drive the ecosystems required to create social value through collaboration with customers and partners, and to promote new external services, knowledge and technologies. more info >> |
|
|
NEC、物流倉庫における入出荷作業の生産性向上に向け次世代型自動搬送ロボットを活用したソリューションを開発 |
| NECは、物流現場での入出荷作業の生産性を向上させる次世代型の自動搬送ロボット(以下、AGV)を活用したソリューションを開発しました。今後、本ソリューションの商用化にむけ、物流会社などとの実証実験を行い2022年3月までに本ソリューションの商用化を目指します。 more info >> |
|
| Thursday, December 16, 2021 |
|
|
NEC Develops Secure Biometric Authentication Technology to Enable Certification with Encrypted Face Information |
| NEC Corporation (TSE: 6701) today announced the development of a secure biometric authentication technology that allows users to authenticate themselves with encrypted face information. more info >> |
|
| Wednesday, December 15, 2021 |
|
|
BostonGene and NEC Announce Global Partnership |
| BostonGene Corporation and NEC Corporation (TSE: 6701) today announced a strategic global partnership agreement that will enable the companies to offer new windowBostonGene Tumor Portrait Tests in key international markets, including Japan as the first market outside of the U.S. more info >> |
|
|
|
|
